In December, two reports in the New York Times called attention to the potential link between paraquat, a strong pesticide, and Parkinson’s disease (PD). The pesticide, which has been previously linked to Parkinson’s, is banned in some countries including those where it is manufactured, but not in the US. What should people with Parkinson’s know about this news?
Earlier this month, Congress approved, and President Obama signed, the Cures Act, formally known as the 21st Century Cures Act. Along with scores of other voluntary health and research organizations, the Parkinson’s Disease Foundation (PDF) applauds this move as one that will confront diseases head-on and accelerate research seeking cures. In this decisive, bipartisan move — too rare in these politically-divided days — the federal government has signaled its confidence that science can help us deliver on the elusive dream of drawing the curtain on diseases including Parkinson’s.
My wife, Marilyn, and I are constantly reminded of the critical role that health professionals play in helping us live our lives to the fullest with Parkinson’s disease. That’s why we work with PDF. Through innovative clinical and online trainings, PDF partners with health leaders to transform PD care. But we need your support to train even more health leaders.
As a scientist, I’m excited to tell you that the future is bright. Our team is discovering new compounds with the potential to ease symptoms and to stop Parkinson’s disease in its tracks. But more than ever, we need your support to make these discoveries a reality. That’s why I’m asking you to support the PDF team working to end Parkinson’s. When you do, donors from the PDF Leadership Circle will match every donation up to $500,000.
By Alan and Cherry Zimmerman Recently, we were asked through the PDF Community Choice Research awards to choose our top priority for Parkinson’s research. We chose caregiver needs. (See our photo at left, or a larger version here.) As you may know, PDF spends $5 million a year on research to solve, treat and end Parkinson’s disease. Through the Community Choice Research Awards, PDF asks the community to help identify other unmet needs not being addressed by research.
One day, we hope to offer treatments tailored to the individual needs of each person with Parkinson’s. But how can we do that if we don’t understand how genetics impact Parkinson’s? After all, our genes are part of what make us unique, including how they relate to our health. This issue came up last week in Nature, when a group of researchers released findings from research in which they analyzed 2,500 genetic studies conducted in 2016 that studied the genes of more than 35 million people. They compared this to a similar analysis from 2009. They found that in 2016, the… Read More